This website uses cookies to enhance the user experience.
||
F

FRESENIUS KABI NORGE AS980 250 008

Purchase and sale
Limited company
Innspurten 9 0663 OSLO, Norge

FRESENIUS KABI NORGE AS

Operating
Handel med parenterale og medisinske infusjons- og nutrisjonsprodukter samt liknende produkter, og virksomhet som står i denne forbindelse.
Salg av legemidler og liknende preparater.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

Chairman of the board
Years since formation
28 years
since Oct 30, 1998
Type
Limited company
VAT registered
Yes
Number of employees
25

Ownership

Number of shares and share classes
50,670
1 share class
Total number of shareholders
1
person
Belongs to group of

Financials

Total operating income 2024
1,313,713,000
NOK
Annual total result 2024
66,298,000
NOK
Total equity 2024
651,413,000
NOK
Last update: Jan 14, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Board Member-
Board Member-
Chairman-

Others

NameRoleShares
B
BDO AS
Auditor-
A
AZETS INSIGHT AS
Accountant-
Last update: Jan 14, 2026

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
50,670
100 %

Shares owned by the FRESENIUS KABI NORGE AS

NameShare classTotal number of sharesShare
S
SVINESUNDVEIEN 80 II AS
Ordinary shares
100
100 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2024: NOK 1,313,713,000
    Operating profit 2024: NOK 78,496,000
    Employees: 25

Financials

in NOK

Summary

Year2024202320222021
Total operating income
1,313,713,000
2,271,258,715
2,021,287,000
1,583,265,000
Annual Total Result
66,298,000
45,817,260
194,910,000
147,703,000
Total assets
1,833,046,000
1,953,203,929
1,993,627,000
1,772,253,000
Total liabilities
1,181,633,000
468,089,016
555,485,000
429,021,000
Total equity
651,413,000
1,485,114,913
1,438,142,000
1,343,232,000

P&L

Year2024202320222021
Total operating income
1,313,713,000
2,271,258,715
2,021,287,000
1,583,265,000
Total operating costs
1,235,217,000
2,234,773,993
1,808,854,000
1,386,924,000
Operating result
78,496,000
36,484,723
212,432,000
196,341,000
Financial income/costs
10,653,000
22,305,434
43,516,000
-7,030,000
Profit before tax
89,149,000
58,790,157
255,948,000
189,311,000
Total tax & extraordinary income/cost
22,851,000
12,972,897
61,038,000
41,608,000
Annual Total Result
66,298,000
45,817,260
194,910,000
147,703,000

Balance overview

Year2024202320222021
Total fixed assets
606,864,000
401,486,427
508,223,000
525,187,000
Total current assets
1,226,182,000
1,551,717,502
1,485,405,000
1,247,066,000
Total assets
1,833,046,000
1,953,203,929
1,993,627,000
1,772,253,000
Short term debt
1,172,913,000
442,468,925
493,375,000
361,748,000
Long term debt
8,720,000
25,620,091
62,110,000
67,273,000
Total liabilities
1,181,633,000
468,089,016
555,485,000
429,021,000
Contributed capital
50,670,000
50,670,000
50,670,000
50,670,000
Retained earnings
600,743,000
1,434,444,913
1,387,472,000
1,292,562,000
Total equity
651,413,000
1,485,114,913
1,438,142,000
1,343,232,000
Total equity and liabilities
1,833,046,000
1,953,203,929
1,993,627,000
1,772,253,000

Classification

21st company classification
BETA
Industrial large enterprise
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods